Global Head, Scientific Communication and Publications

Global Head, Scientific Communication and Publications – Oncology Location: Raritan, New Jersey, United States of America. Position Summary: This leadership role provides enterprise direction for the development and execution of global scientific communication strategies across the oncology franchise, covering both hematologic malignancies and solid tumors. The Global Head is accountable for shaping and delivering a consistent, high‑impact external scientific narrative across marketed and investigational assets, and for leading a global organization that includes scientific communications, publications, and medical content. The role partners closely with Global Medical Affairs Leaders, Strategy & Execution Leads, Clinical Development Teams, R&D, Market Access, and regional leadership to integrate scientific communications with evidence generation and medical strategy. Major Responsibilities Franchise Scientific Communications Leadership Define and lead global scientific communication strategies across the oncology franchise, ensuring a consistent, differentiated, and aligned external scientific narrative across therapeutic areas and assets. Global Publication Strategy & Prioritization Establish, prioritize, and oversee global publication strategies and execution across the asset lifecycle; define publication investments and ensure alignment with evidence generation plans and portfolio priorities across Hematology and Solid Tumor portfolios. Organizational Leadership & Talent Development Lead and develop a global team of scientific communication and publication leads across therapeutic areas and key assets; provide coaching, talent development, and performance management while building scalable capabilities. Medical Content Strategy Provide strategic oversight of the One Content Plan and global medical content strategy, ensuring integrated planning, prioritization, and consistent scientific messaging across global and regional stakeholders. Enterprise Cross‑functional Integration Serve as a senior strategic partner to GMALs, SELs, CDTs, R&D, and Market Access leadership to align scientific communications with evidence generation, data readouts, and lifecycle strategy. Governance, Performance & Execution Excellence Establish governance models (e.g., publication steering committees), KPIs, and performance metrics to ensure high‑quality, timely, and compliant execution across assets; proactively identify risks and drive mitigation strategies. Vendor Strategy & External Engagement Define and oversee global vendor strategy and agency partnerships with a focus on vendor efficiency; represent the Company in external scientific forums, including engagement with journals, congress leadership, academic institutions, and key opinion leaders. Scientific Content Oversight Provide strategic guidance and oversight on the development of scientific communication outputs (e.g., abstracts, manuscripts, congress materials, scientific communication plans, lexicons) to ensure quality, consistency, and alignment with the overall scientific narrative. Innovation & Digital Enablement Drive adoption of innovative approaches, including AI and digitally enabled capabilities, to enhance efficiency, insight generation, and impact of scientific communications. Compliance & Policy Leadership Ensure adherence to Company policies, publication SOPs, and industry standards (e.g., GPP), including oversight of authorship, copyright, and embargo requirements. Accountability Own and deliver an integrated global scientific communications and publication strategy for the oncology franchise, ensuring consistent execution of high‑quality scientific communications across Hematology and Solid Tumor portfolios. Provide strategic oversight and input into Integrated Evidence Generation Plans, with accountability for publication and dissemination strategy. Lead enterprise publication governance, including steering committees and cross‑functional decision‑making forums; ensure organizational compliance with applicable policies, SOPs, and industry standards. Drive operational excellence in planning, execution, resource allocation, and budget management across the function. Qualifications Advanced degree required (PharmD, PhD, MD, or equivalent). Significant experience (typically 12+ years) in scientific communications, publications, or global medical affairs. Demonstrated leadership across oncology portfolios, including both hematologic malignancies and solid tumors. Proven experience leading global teams, including direct management of senior leaders. Strong strategic thinking with ability to translate complex scientific data into impactful communication strategies. Experience operating in a highly matrixed global environment with ability to influence senior stakeholders. Experience managing large‑scale budgets, vendor ecosystems, and external partnerships. ISMPP certification or equivalent expertise in publication standards preferred. Up to ~25% domestic and international travel may be required. Compensation Base salary range: $196,000 – $342,700. The position is eligible for an annual performance bonus and a long‑term incentive program. The Company maintains highly competitive, performance‑based compensation programs in accordance with applicable plans. Benefits (summary) Medical, dental, vision, life insurance, short‑term and long‑term disability, and business accident insurance. Group legal insurance and a consolidated retirement plan (pension) and savings plan (401(k)). Paid vacation (up to 120 hours per calendar year), sick time (up to 40 hours per calendar year; up to 56 hours for Washington residents), holiday pay, floating holidays, and work‑personal‑family time (up to 40 hours per calendar year). Equal Opportunity Employment Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. The Company actively seeks qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act. Johnson & Johnson is committed to providing an interview process that is inclusive of applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please contact us via or contact AskGS to be directed to your accommodation resource. #J-18808-Ljbffr 6085-Janssen Global Services, LLC Legal Entity